Genelux GNLX
NASDAQ GNLX
$1.98 -0.09 (-4.35%)
At close: Oct 22, 2026 · 4:00 PM EDT

Genelux (GNLX) EBIT Margin (2022 - 2024)

Updated

Genelux's EBIT Margin was -415175.00% in FY2025, down 18975.00 percentage points from -396200.00% in FY2024.

Analysis

Genelux (GNLX) EBIT Margin (2022 - 2024) Analysis & Trends

From FY2022 onward, Genelux has reported EBIT Margin for 4 years.

  • EBIT Margin has now declined for three consecutive years, with a three-year change of -415147.78 percentage points (FY2022 to FY2025).
  • Per Business Quant data, EBIT Margin in earlier years was -396200.00% in FY2024 (-381985.29 pp), -14214.71% in FY2023 (-14187.48 pp) and -27.22% in FY2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT Margin (Qtr)
1 Eli Lilly 1,165.22 Bn 1,133.81 Bn 19.71 Bn 51.16%
2 Johnson & Johnson 646.28 Bn 566.14 Bn 17.30 Bn 24.35%
3 AbbVie 503.17 Bn 476.28 Bn 12.70 Bn 37.86%
4 Merck 365.23 Bn 319.60 Bn 12.21 Bn -3.52%
5 Novartis Ag 302.66 Bn 266.65 Bn 11.24 Bn 32.97%
6 Astrazeneca 267.39 Bn 241.08 Bn 12.86 Bn 20.57%
7 Amgen 241.61 Bn 197.01 Bn 7.24 Bn 34.95%
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn -133.21%
9 Pfizer 172.91 Bn 119.55 Bn 10.94 Bn 28.37%
10 Genelux 88.08 Mn 26.36 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2024 -101,437.50%
Mar 31, 2023 -3,801.18%
Dec 31, 2022 -4,550.00%
Sep 30, 2022 57.67%
API Access

Genelux EBIT Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebit-margin&ticker=GNLX&period=max&api_key=YOUR_API_KEY